Xenopus in vitro studies have implicated both transforming growth factor ␤ (TGF-␤) and fibroblast growth factor (FGF) families in mesoderm induction. Although members of both families are present during mouse mesoderm formation, there is little evidence for their functional role in mesoderm induction. We show that mouse embryonic stem cells, which resemble primitive ectoderm, can differentiate to mesoderm in vitro in a chemically defined medium (CDM) in the absence of fetal bovine serum. In CDM, this differentiation is responsive to TGF-␤ family members in a concentration-dependent manner, with activin A mediating the formation of dorsoanterior-like mesoderm and bone morphogenetic protein 4 mediating the formation of ventral mesoderm, including hematopoietic precursors. These effects are not observed in CDM alone or when TGF-␤1, -␤2, or -␤3, acid FGF, or basic FGF is added individually to CDM. In vivo, at day 6.5 of mouse development, activin ␤A RNA is detectable in the decidua and bone morphogenetic protein 4 RNA is detectable in the egg cylinder. Together, our data strongly implicate the TGF-␤ family in mammalian mesoderm development and hematopoietic cell formation.
The factors and their interactions which mediate the development of mesoderm from primitive ectoderm and subsequent pattern formation in mammals have yet to be elucidated. In Xenopus laevis, there is strong evidence that mesoderm formation is the result of vegetal hemisphere cells of the blastula inducing or acting upon the overlying equatorial and animal pole cells. These data were obtained in part by using the animal hemisphere region of the embryo as an in vitro assay system for mesoderm-inducing factors. Such assays have implicated members of the transforming growth factor ␤ (TGF-␤) superfamily and the fibroblast growth factor (FGF) family in Xenopus mesoderm induction and development (see reviews in references 23, 27, and 61) .
Mesoderm will develop during embryogenesis into tissues as diverse as muscle and hematopoietic cells. By using Xenopusbased models, it has been shown that the developmental fate of mesoderm can be influenced by both the nature of the inducing factor and its concentration. For example, the TGF-␤ family member activin A (homodimers of which are known as activin ␤A or inhibin ␤ A ) induces mesoderm of a dorsoanterior nature in Xenopus explants (2, 18, 64, 65, 68) . Another member of the TGF-␤ superfamily, bone morphogenetic protein 4 (BMP-4; also known as BMP-2b or DVR-4), appears also to be involved in mesoderm development (see review by Wozney et al. [78] ). In this case, BMP-4 mediates mesoderm formation of a more ventral character, including hematopoietic cells (12, 30, 37) .
In mammals, there is a lack of such data. This paucity of information concerning mammalian mesoderm formation is in part due to the difficulty in manipulating mouse embryos at the relevant stages (days 5.5 to 8.5 postcoitum [p.c.]) and partly to the lack of any similar pathfinder in vitro system. Mouse embryonic stem (ES) cells are derived from the inner cell mass of the 3.5-day blastocyst. They have similarities to both the inner cell mass of the blastocyst and the primitive ectoderm of the day 5-6 egg cylinder (16, 43) . ES cells have a normal karyotype and can, when returned to the maternal or embryonic environment, give rise to the complete development of the mouse (44, 45) . In the absence of leukemia inhibitory factor (LIF) (62, 74) and in the presence of serum, ES cells differentiate in vitro ''spontaneously'' to mesoderm and hematopoietic cells (8, 14, 34, 58, 71, 72) . Such a model system has the promise of allowing the rapid analysis of growth factors effects, singly and in combination. However, although the use of ES cell differentiation as an in vitro model of early mouse or mammalian development has existed for some time, it appears to be unresponsive to many factors tested or else has yielded contradictory results (e.g., see references 5, 34, and 70). We believe that this discrepancy is due to the presence of fetal bovine serum (FBS) and/or human cord serum at 10 to 20% in the culture medium used for these studies. Serum contains variable amounts of factors, including activin A (55) and interleukin-6 (IL-6) (5), plus many other ill-defined substances. These uncontrolled influences will mask or at least complicate the analysis of growth factor effects on ES cell differentiation in vitro. Consequently, the amount of information gained on growth factor involvement during early mammalian embryogenesis has been limited.
To overcome these problems, we developed a completely chemically defined medium (CDM) in which ES cells will survive in the absence of serum. Additionally, ES cell differentiation in CDM is responsive to exogenously added factors, allowing the analysis of their influence on mesoderm formation and subsequent development. We present data showing that ES cell differentiation to mesoderm in CDM alone is very poor but is enhanced by the addition of activin A or BMP-4. It is also shown that in CDM, the type of mesoderm which develops can be directed, with activin A mediating a dorsoanterior-like mesoderm and BMP-4 mediating the formation of a more posterior or ventral mesoderm, including hematopoietic development. These data are consistent with reports of in vitro mesoderm induction in the amphibian animal cap assay system.
In an attempt to determine whether our observations in vitro are relevant to data obtained in vivo, we also examined embryonic tissues at days 5.5 and 6.5 days p.c. for the expression of activin ␤A and BMP-4. Data are presented which show that RNAs coding for these factors are present during mouse development in a manner consistent with a putative role in mesoderm induction. Together, these findings indicate that members of the TGF-␤ family are implicated in mammalian mesoderm and early hematopoietic development.
MATERIALS AND METHODS
ES cell culture and differentiation. The ES cell line CCE (129/Sv/Ev derived) was adapted to grow in the presence of LIF (1,000 U/ml; ESGRO; Gibco-BRL catalog no. 3275SA) and in the absence of feeder cells (50, 72) . The cells were routinely maintained on gelatinized flasks in Dulbecco's modified Eagle's medium supplemented with LIF, 15% FBS, and 150 M monothioglycerol. Serum batches were chosen to give a high plating efficiency of undifferentiated ES cells in the presence of LIF. The CCE ES line used in this study was capable of producing germ line transmission before being taken off feeder cells (not shown). ES cells were maintained for a maximum of 20 passages in the absence feeders for these experiments. Under these conditions, CCE cells required passaging every 2 to 3 days. ES cell lines D3 (129/Sv derived) and E14.1 (129/Ola derived) were maintained in the same media but on gamma-irradiated STO feeders (14, 17, 50) .
For the standard CDM differentiation studies, ES cells were trypsinized to single cells and washed free of LIF, and 5,000 cells seeded into a 35-mmdiameter bacterial grade dish in 1 ml of CDM. This would give rise to 10 to 20 embryoid bodies (EBs) per ml after 5 days. It was found essential to maintain any carryover of LIF or FBS into the CDM via the introduced ES cells to less than ϳ0.1 U of LIF per ml and below ϳ0.05% FBS. The basic CDM consisted of Iscove's modified Dulbecco's Medium plus Ham's F12 medium at a 1:1 ratio, both supplemented with Glutamax-I (Gibco-BRL, Life Technologies Inc.) as source of glutamine; bovine serum albumin at a final concentration of 5 mg/ml (Boehringer Mannheim catalog no. 652 237); lipids at 1ϫ (100ϫ mixture of chemically defined lipid concentrate [Gibco-BRL, Life Technologies Inc. catalog no. 066-01905H]); transferrin at a final concentration of 15 g/ml (Boehringer Mannheim catalog no. 1073982); monothioglycerol at 450 M, insulin at 7 g/ml; Redu-SER (an insulin-transferrin-selenium mixture used to provide an additional 10 g of insulin, 10 g of transferrin, and 10 ng of sodium selenite per ml [Upstate Biotechnology, Inc., Lake Placid, N.Y.]; later experiments indicated that Redu-SER was not necessary); and LIF at 1 U/ml. CDM was prepared on the day of use. As a control in some experiments, ES cells were differentiated for 4 days in Iscove's modified Dulbecco's medium with 10% FBS and 450 M monothioglycerol (34, 71) .
Except where stated, exogenous factors were added at day 0 of differentiation. The ES cell/EB culture medium was not changed during the experimental period. Purified recombinant human activin A, human BMP-4 (both as homodimers), and human IL-11 were gifts from the Genetics Institute Inc. (Cambridge, Mass.). Other factors used were human TGF-␤1 (Sigma catalog no. T-1654), human acid FGF (Boehringer Mannheim catalog no. 1376462), human basic FGF (Gibco-BRL catalog no. 3256SA), biologically active TGF-␤2 and -␤3 (gifts of G. McMaster and N. Cerletti, Ciba-Geigy AG, Basel, Switzerland), mouse IL-6 (Pharmingen [San Diego, Calif.] catalog no. 19006V), human erythropoietin (Cilag AG, Schaffhausen, Switzerland), and porcine sodium heparin (Upstate Biotechnology catalog no. 11-102).
Methylcellulose colony precursor assays were performed on day 8 EBs as outlined previously (34) except that trypsin was used to dissociate the EBs. The myeloid precursor assays contained 10% FBS, 2 U of erythropoietin per ml, L-cell conditioned medium as a source of macrophage colony-stimulating factor and other factors, and mouse IL-3 (32) and human IL-1␣ (a gift from P. Lomedico, Hoffmann-LaRoche, Nutley, N.J.) at 100 U/ml.
Whole-mount in situ hybridization. Whole-mount in situ hybridization for brachyury RNA expression was performed on EBs grown in Iscove's modified Dulbecco's medium with 15% FBS (batch selected) and 450 M monothioglycerol for 4 days or on EBs grown in CDM with or without activin A or BMP-4 for 5 days. The brachyury probe was cloned from EBs differentiated in FBS by reverse transcription (RT)-PCR (primers used are indicated in Table 1 ) and was blunt-end cloned into Bluescript (Stratagene) (34) . Probe identity and orientation were confirmed by restriction enzyme mapping. Digoxigenin-UTP sense and antisense probes were synthesized as outlined by the manufacturer (Boehringer Mannheim). Hybridization and signal visualization using an anti-digoxigenin Fab-alkaline phosphatase conjugate (Boehringer Mannheim) were performed exactly as described elsewhere (53) . In situ development periods and camera settings were the same for all in situ studies.
RT-PCR. Semiquantitative RT-PCR was performed as described before (34) . Briefly, total RNA was isolated by the acid guanidinium-phenol-chloroform method (10) . RNA precipitation was aided by adding 50 g of glycogen per ml; the resultant RNA was subjected to DNase treatment to remove any contami- nating DNA. All cDNAs were tested for the presence of contaminating genomic DNA by PCR. cDNA was synthesized by using oligo(dT), and the resulting cDNA was quantified by PCR, using HPRT (hypoxanthine phosphoribosyltransferase) as a standard (Table 1) . RT-PCR was performed with an AMS Biotechnology (Europe) Protocol thermal cycler, operating on a regimen of 96ЊC for 5 s, 50 or 55ЊC for 15 s (see Table 1 for exact temperatures), and 72ЊC for 60 s for 30 (32 cycles for brachyury), followed by 72ЊC for 10 min. PCRs of 15 l used cDNA derived from an estimated 20 cells for HPRT standardization and 20 or 100 cell equivalents of cDNA for all other genes (34) . Multiplex RT-PCR was performed with a combination of primers for HPRT (internal standard) combined with the test gene primers. For RT-PCR of collagen IV and BMP-4, the amount of cDNA used was equivalent to 20 cells. In the case of multiplex RT-PCR assays for brachyury, the amount of cDNA used (100 cell equivalents) would cause the HPRT signal to out-compete any brachyury signal. To avoid this, four cycles of PCR were performed first in the absence of the HPRT primers, which were then added to the reaction in a volume of 5 l, i.e. giving a final PCR reaction volume of 20 l. This reaction was then subjected to a further 28 cycles (annealing at 55ЊC). Half of the PCR product was electrophoresed rapidly in tris-borate buffer through a 1.2% agarose gel (56) . The PCR products were visualized by ethidium bromide staining and photographed. For multiplex RT-PCR experiments, the resulting agarose gels were Southern blotted onto GeneScreen Plus (Du Pont) as recommended by the manufacturer and hybridized with probes for HPRT and brachyury or BMP-4. Filters were washed in 0.1ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) plus 0.1% sodium dodecyl sulfate at 65ЊC for twice for 20 min each time (56) . Signals were visualized and quantified with a PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.) to estimate the relative ratio of HPRT signal to test gene signal (28) . Most PCR primers were selected with assistance from MacMolly Tetra software (Soft Gene GmbH, Germany). Criteria for optimization and primer specificity were as published before (34) . Wherever possible, PCR primers were optimized by using 0.5 ng of genomic DNA per 15-l PCR reaction, equivalent to approximately 170 copies of an autosomal gene. This also gave an indication of the relative efficiency of the different primer pairs. PCR primers for BMP-2, BMP-4, and BMP-6 were designed to avoid (known) homology to other known TGF-␤ members and in particular to each other. Additionally, the BMP-4 RT-PCR product was cloned and sequenced to verify its identity.
Studies on mouse embryos used C57/BI6 ϫ DBA2 (BDF1) mice. Noon of the day of appearance of the copulation plug was regarded as day 0.5. Staging of dissected embryos was verified visually on the basis of published criteria (33, 54) . Embryos were treated in the same manner as ES cells and EBs for RNA isolation, DNase treatment, cDNA synthesis, and HPRT standardization. Embryo RT-PCRs used material derived from single embryos (i.e., not pools of embryos).
RESULTS

ES cells survive and differentiate in CDM in the absence of FBS.
To remove the effect of serum on ES cell differentiation in vitro, we developed a serum-free CDM based on suggestions by Iscove (25) . In monolayer, in CDM plus LIF at 1,000 U/ml (a level which will inhibit differentiation under conventional culture), CCE (without feeder cells) and E14.1 (on feeder cells) ES cells maintained a morphology and growth rate similar to those of ES cells grown in FBS containing medium for three passages (8 to 10 days). Rex-1, used here as a marker of undifferentiated ES cells, continued to be expressed at high levels in these cultures (51, 59) (Table 2 and data not shown). However, when the ES cells (CCE or E14.1) were maintained for longer than three passages in CDM plus LIF (1,000 U/ml), phase-contrast microscopy revealed a population of cells arising with a non-ES cell morphology (data not shown). The nature of this alteration in phenotype is under investigation.
When ES cells are seeded in suspension culture in CDM in the absence of LIF, they form clumps of cells (EBs) within 24 h. However, within 72 h, the cells die. Titrations with LIF added to CDM indicated that ES cell lines CCE, D3, and E14.1 will survive, proliferate, and differentiate, albeit inefficiently, in CDM containing 1 U of LIF per ml. ES cell/EB differentiation status was monitored by the of loss of Rex-1 expression and the gain of brachyury expression (Table 2) (34, 73) . It was also noted that the initial ES cell plating density strongly affects subsequent ES cell/EB differentiation. At cell densities equal or greater than 10,000 cells per ml in CDM, ES cell differentiation was inhibited (Table 3) ; this effect is presumably due to a factor(s) produced by the ES cells themselves, such as LIF (19) . All subsequent differentiation studies used a suspension of 5,000 cells per ml of CDM plus 1 U of LIF per ml per 35-mm-diameter non-tissue culture plate.
Time course studies were conducted on ES cells and EBs grown in CDM as described in Materials and Methods. By day 3 of differentiation, Rex-1 RNA was down-regulated. By day 5, a very low level of brachyury RNA was detectable by RT-PCR (Table 3 and Fig. 1 ). Similar RT-PCR data were obtained with the ES cell lines D3 and E14.1 (not shown). By whole-mount in situ hybridization, brachyury RNA was detectable in 5 to 10% of all EBs grown in CDM, compared with approximately 90% of all EBs grown in the presence of 15% FBS (Fig. 2) . A member of the TGF-␤ superfamily of factors (see review in reference 77). Xenopus BMP-4 can induce mesoderm-specific markers in Xenopus cells (10) . In the mouse, BMP-4 was cloned from a 6.5-p.c.-day egg cylinder library. By 7.5 days p.c., transcripts are localized by in situ, first to the allantois and amnion; by 8.5 days, they are found in the posterior-ventral tissues of the primitive streak (29) . Brachyury A putative transcription factor. Expression begins at gastrulation and is restricted to the primitive streak and mesoderm emerging from the streak. Later, it is found in the head process and the notochord (22, 73) . With the in vitro Xenopus model system, activin A, basic FGF (63), and BMP-4 (12) can all induce brachyury expression. FGF-5 FGF-5 mRNA is found in the embryonic ectoderm just prior to gastrulation at around day 6 of development (21) . A low level is also detectable in ES cells; however, upon cell differentiation, this level increases substantially (59) . Goosecoid A homeobox gene expressed as a patch on the side of the epiblast where the primitive streak is first formed and then at the anterior end of the developing primitive streak. Subjecting the day 6-6.5 egg cylinder to activin A results in goosecoid mRNA accumulation in the entire epiblast, suggesting that activin A is responsible in vivo for this induction (6) . Nodal A member of the TGF-␤ superfamily of factors. Expression is first detected in primitive streak-stage embryos at mesoderm formation. Later it is localized to the node at the anterior of the primitive streak and is possibly involved in the organization of axial structures (79). Rex-1 Encodes a zinc finger protein which is highly expressed in ES cells and decreases upon their differentiation (51, 59).
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Brachyury RNA was localized in clusters of cells within the EBs. Signal intensity was heterogeneous but appeared not to be related to the mass of the EBs and is more likely a reflection of stochastic events within the EBs. No hematopoietic activity was detected (at 5 and 8 days). Although there was some cell death over the first few days of differentiation in CDM, there was an overall cell number increase of approximately 20-fold after 5 days of culture. Thus, CDM allows ES cells to survive, proliferate, and undergo a very low level of spontaneous differentiation. Hence, we reasoned that ES cell differentiation may now be more responsive to exogenously added factors.
Activin A mediates mesoderm formation during ES cell/EB differentiation in CDM. Purified activin A, a growth factor which has been shown to induce mesoderm in vitro in the Xenopus animal cap system (2, 64, 65, 68) , was added at the initiation of ES cell differentiation in CDM over a range of 0.5 to 10 ng per ml. EBs which developed in CDM with 0.5 to 10 ng of activin A per ml showed a slightly enhanced (20 to 30%) growth compared with cells grown in CDM alone at day 5 of differentiation. To monitor mesoderm formation, multiplex RT-PCR was performed with primers specific for brachyury and HPRT (used here as an internal cDNA RT-PCR standard). Brachyury expression showed a maximum with 2 ng of activin A per ml at day 5 of differentiation. Similar results were obtained with ES cell lines D3 and E14.1 (data not shown). When the concentration of activin A was increased to 10 ng/ml, expression at day 5 was less than with CDM alone (Fig. 1 and Table 4 ; summarized in Table 5 ). Whole-mount in situ hybridization for brachyury RNA on EBs grown for 5 days in CDM plus activin A at 2 ng/ml showed an increase of both signal intensity and frequency of positive EBs (20 to 30% of all EBs). The EB population was heterogeneous for brachyury expression at day 5, possibly because of a loss of synchronization or random stochastic events within the developing EB. Hence, the level seen by RT-PCR is a reflection of the average brachyury expression of the whole culture. After the addition of heparin, the effect of activin A on brachyury up-regulation was not observed.
Blum et al. had previously shown that activin A could induce the up-regulation of goosecoid RNA in the day 6 mouse egg cylinder (6) . In agreement with these observations, goosecoid RNA was found to be up-regulated in EBs grown in CDM plus activin A (0.5 to 10 ng/ml, at day 5 of differentiation; Table 4 ). Levels of expression of Evx-1, FGF-5, and nodal were also increased compared with CDM alone (Tables 2 and 4 ). In contrast, BMP-2, BMP-4, BMP-6, and activin ␤A RNAs were present at only trace levels, equivalent to those found in CDM alone.
The abundance of collagen IV RNA, a marker for endoderm, was also monitored by RT-PCR (1, 69) . In multiplex RT-PCR (collagen IV versus HPRT), expression of collagen IV RNA was found to be only slightly elevated in the presence of activin A compared with CDM alone (Table 4 ; summarized in Table 5 ).
Expression of ␤H1 was used as an indicator of hematopoietic activity. Over the range of activin A concentrations tested, no significant hematopoietic activity was detected by RT-PCR after 5 or 8 days of differentiation. Myeloid colony assays were also performed with EBs differentiated for 8 days with or without activin A at 2 ng/ml. No hematopoietic precursors could be detected with EBs grown in CDM with or without activin A (Ͻ1 in 10 5 cells). After 9 to 12 days of differentiation in CDM plus 2 ng of activin A per ml, 10 to 20% of all EBs were spontaneously beating, indicative of cardiac muscle. In cultures treated with Ն1.5 ng of activin A per ml for 8 days, alpha cardiac myosin heavy chain, a marker of cardiac muscle, was readily detectable by RT-PCR (49) . In contrast, in CDM alone or at Ͻ1.5 ng/ml activin A, alpha cardiac myosin RNA was not detectable (Table 4).
BMP-4 mediates the development of both mesoderm and hematopoietic cells in ES cell/EB differentiated in CDM. Another strong contender for a role in mesoderm induction in X. laevis, especially of a more ventral nature, is BMP-4 (12) . BMP-4 was tested over a concentration range of 60 pg to 10 ng/ml for its ability to influence ES cell/EB differentiation in CDM. ES cells and EBs seeded into CDM with BMP-4 at 0. a CCE ES cells were seeded in CDM as described in Materials and Methods. After 5 days, EBs were harvested for RNA isolation and cDNA synthesis. RT-PCR was performed on cDNA equalized by using HPRT as a standard. Differentiation was monitored by using REX-1 and brachyury expression (see Table 2 ).
b Thirty-five cycles of PCR were performed for these experiments only. (Fig. 2) . ␤H1 RNA (at day 5) and myeloid hematopoietic precursors (at day 8) were readily detectable if BMP-4 was present in the culture system. The concentrations of BMP-4 required for maximal mesoderm formation and hematopoiesis at day 5 of differentiation were strikingly different. BMP-4 at 0.25 ng/ml (ϩ0.2 Ϫ0.1 ng/ml between experiments) was optimal for the mesoderm markers monitored, whereas 2.0 ng/ml (Ϯ0.5 ng/ml between experiments) was optimal for ␤H1 expression and hematopoietic precursor formation (Fig. 3, Table 4 , Table 5 , and data not shown). At day 5 of differentiation, in the presence of BMP-4 at Ն2.0 ng/ml, brachyury RNA abundance was reduced to below the basal level. Also over the range of BMP-4 concentrations tested at day 5, activin ␤A, FGF-5, nodal, and goosecoid RNAs were not detectable or were present at trace levels. In contrast, BMP-2, BMP-4, and BMP-6 RNA levels were higher than in CDM alone, and their expression was coincident with that of brachyury ( Table 4) . Expression of collagen IV was found to be slightly elevated in the presence of BMP-4 than in CDM alone.
After 9 to 12 days, 20 to 40% of EBs differentiated in CDM with 0.25 ng of BMP-4 per ml were spontaneously beating, with many showing complex cystic structures. At higher concentrations of BMP-4, EBs were of a more solid nature and the percentage of beating EBs diminished. RT-PCR confirmed the presence of alpha cardiac myosin heavy chain and the effect of BMP-4 concentration on expression (Ն0.25 to Յ1.5 ng at day 8 of differentiation; Table 4 ). Additionally, at 2.0 ng of BMP-4 per ml, 20 to 40% of all EBs showed blood islands; RT-PCR confirmed the presence of both ␤H1 and ␤ major globin. The effects of other factors tested on ES cell and EB development in CDM. By using the Xenopus in vitro animal cap mesoderm induction assay, other members of both the TGF-␤ and the FGF families have been implicated in mesoderm development (13, 24, 60) and in avian development (11) . These and other factors were tested (listed in Table 5 experiments reported above, the factors were added once, at the initiation of differentiation. In the presence of acid FGF at 0.1 to 10 ng/ml, basic FGF at 0.1 to 10 ng/ml, or TGF-␤1, -␤2, or -␤3 at 0.1 to 10 ng/ml, there was no consistent striking increase in mesoderm formation (as defined by brachyury and goosecoid expression) or hematopoiesis (␤H1 expression) following 5 or 8 days of differentiation over that found in CDM alone. Trace signals for brachyury were detected in some experiments with TGF-␤1 or basic FGF, but neither showed a consistent response over the concentration ranges or time periods examined. Other factors tested, including erythropoietin, IL-6, IL-11, and steel (also known as KL or SCF), showed either no detectable or only slight variable signals for the markers tested. A slight increase in both plating efficiency and EB size was noted with IL-11 at Ն3 U/ml, IL-6 at Ն1 ng/ml, acid FGF at Ն1 ng/ml, and basic FGF at Ն1 ng/ml. Kinetics of mesoderm formation with activin A and BMP-4. By using Xenopus animal cap cells, it has been shown in vitro that the expression of brachyury occurs rapidly in response to activin A, even in the presence of a protein synthesis inhibitor (63) . Therefore, the kinetics of mesoderm development from 0 to 8 days in CDM with or without activin A or BMP-4 were examined by using multiplex RT-PCR.
In the presence of activin A at 2 ng/ml, significant levels of brachyury RNA were not detectable until day 4 of differentiation, after which brachyury RNA abundance continued to increase over the following 4 days (Fig. 4) . In the case of BMP-4 at 0.25 ng/ml, brachyury expression was again not significant until day 4 of differentiation; however, peak expression occurred on day 4. After this time, the level decreased rapidly, being undetectable at days 7 and 8 (Fig. 4) . Additionally, both nodal and goosecoid expression, although virtually undetectable at day 5 of differentiation in 0.25 ng of BMP-4 per ml, was found to be briefly expressed on day 4 (data not shown). When BMP-4 was increased to 2.0 ng/ml, the onset of brachyury expression was slightly more rapid, showing a peak of expression at days 3 or 4 (Fig. 4) . However, expression decreased rapidly after this time, and by day 5, brachyury expression was virtually undetectable. At 2.0 ng of BMP-4 per ml, again both nodal and goosecoid showed a brief wave of expression, being readily detectable at days 3 or 4 and virtually absent by day 5 (data not shown).
To determine whether activin A or BMP-4 acts directly on ES cells or on a cell type that develops after a few days of differentiation, the factors were added from 0 to 4 days after initiation of differentiation. EBs were harvested for RT-PCR analysis on day 5. Brachyury expression was detected in cultures with activin A (2.0 ng/ml) or BMP-4 (0.25 ng/ml), even if the factor had been added only 24 h before harvesting (data not shown). This finding suggests that competence to these factors occurs after 3 to 4 days of ES cell/EB differentiation and that cells can respond within 24 h after reaching competence.
Activin ␤A and BMP-4 RNAs are present in vivo in a manner consistent with a role in mesoderm induction. To begin to determine whether activin A and BMP-4 are physiologically relevant in mesoderm formation for the early mouse embryo, the presence of RNA for both activin ␤A and BMP-4 was examined. As shown previously by in situ hybridization, activin ␤A RNA is not detectable or is present only in trace levels in 
Positive controls ϩ ϩϩ ϩ ϩϩ ϩ ϩϩϩ ϩϩϩ ϩϩϩ ϩ ϩϩ ϩϩ ϩ Ͼϩϩϩ a CCE ES cells were seeded in CDM with or without BMP-4 or activin A at various concentrations, harvested after 5 days, and tested by RT-PCR for the expression of a number of genes. The results shown are from a single representative experiment. Note that for HPRT, BMP-4, and collagen IV RT-PCRs, 20 cell equivalents of cDNA were used; for all other genes, five times more cDNA was used. Alpha cardiac myosin RT-PCR was carried out on EBs grown for 8 days under the same conditions. cDNAs used for positive controls are listed in Table 1 . Water was used as a negative control. Scoring was as described in Table 5 , footnote a.
b Variable between ES cell harvests. ND, not determined.
the egg cylinder at the time of mesoderm formation but is abundant in the decidua (5.5 to 6.5 days p.c.) (Fig. 5) (42) . The variable trace level of activin ␤A detected by RT-PCR in the egg cylinder is probably due to a few decidua cells remaining attached to the microdissected egg cylinder. We did not detect activin ␤A RNA in ES cells (67) (Fig. 5) . In contrast, BMP-4 RNA is present in ES cells (in agreement with the results obtained with embryonic carcinoma cells [52] ), and in the egg cylinder at 6.5 days p.c. (Fig. 5) , but was not detectable in the decidua. It was noted that the abundance of BMP-4 and nodal RNAs both in undifferentiated ES cells and in the 6.5 day egg cylinder was highly variable between samples. This variability is possibly a reflection of the sharp autoregulatory effect of BMP-4 ( Fig.  6) , with the abundance of BMP-4 RNAs being very sensitive to the precise stage of the egg cylinder and the exact state (degree of confluence, FBS batch, etc.) of the ES cells used.
DISCUSSION ES cells in CDM.
CDM containing 1000 U of LIF per ml is capable of supporting ES cell growth in an undifferentiated state for at least 6 days. The nature of the phenotype change observed after 8 to 10 days is not understood, but it appears that in conventional medium, LIF operates in conjunction with unknown factors present in FBS to maintain the ES cell phenotype. In CDM plus 1 U of LIF per ml, a suspension of ES cells forms EBs, continues to proliferate, and after 4 to 5 days exhibits a very low level of spontaneous mesoderm formation. This spontaneous differentiation is probably due to factors (BMP-4, nodal, etc.) synthesized by the ES cells themselves (Table 5) . Mesoderm development is factor dependent. The type of mesoderm which develops in vitro is directed by the nature of the factor and to some extent its concentration. Activin A mediates the formation of dorsoanterior-like mesoderm (extended expression of brachyury and goosecoid), whereas BMP-4 mediates the development of a more posteroventral mesoderm (brief expression of brachyury, nodal, and goosecoid, expression of BMP-4 and ␤H1, and hematopoietic precursor development). These data are consistent with previous reports of studies using the Xenopus animal cap assay. The actual mechanism of mesoderm induction is possibly direct; however, it is more likely that activin A and BMP-4 act via a cascade of other factors and cell-cell interactions.
The increase in BMP-4 RNA abundance observed in response to BMP-4 is significant in models in which sharp threshold effects are thought to be involved. It had been previously reported that BMP-4 would cause its own up-regulation (66); however, the distinct threshold effect that we observed has not been previously reported. Such positive feedback systems would allow cells to respond sharply to changes in a gradient. The increase in abundance of BMP-2 and BMP-6 RNA in response to BMP-4 again indicates the complexity of interactions which are characteristic for the TGF-␤ family. These data also suggest an earlier role than hereto thought for BMP-2 and BMP-6 in mesoderm formation and patterning.
Cardiac muscle formation is mediated by activin A and BMP-4. One of the visually striking features observed with ES cells differentiated in the presence of serum is the appearance of spontaneously beating cardiac muscle (14, 57) . Previous reports had indicated that this effect was dependent upon serum batch; however, the elements in serum which are responsible for this activity are not known. ES cells differentiated in CDM with either activin A or BMP-4 show an enhancement of cardiac muscle formation in a factor concentration-dependent manner. Previously it had been shown that activin A Table 1 ; water was used as a negative (Ϫve) control. Table 1. enhances alpha cardiac myosin heavy-chain gene expression in isolated Xenopus animal pole explants (38) . In addition, in mouse, both activin ␤A and BMP-4 have been found to be associated with cardiac development (36, 40) . Thus, it is quite possible that these TGF-␤ family members are involved in cardiac muscle formation during ES cell differentiation in FBS and in vivo. However, their actual role in vivo in cardiac muscle development remains to be formally demonstrated.
Kinetics of mesoderm development in vitro. The data presented are suggestive of similarities between mesoderm formation in X. laevis and mammals; however, there are differences. In CDM, EBs show brachyury expression in response to activin A or BMP-4 after 3 to 4 days of differentiation. In contrast, in the Xenopus in vitro animal cap assay, activin A induces the expression of Xenopus brachyury within a few hours (63) . This disparity may reflect the different developmental kinetics between mouse and Xenopus cells; for example, fertilization to mesoderm formation in Xenopus cells occurs in 10 h; in mouse cells, this process takes 6 days. Also, ES cells are thought to resemble the inner cell mass more than primitive ectoderm. Thus, they would have to progress to reach a state of competence to mesoderm-inducing factors (59) . This idea is partly supported by the similar timing for the appearance of brachyury and goosecoid RNAs in the presence of activin A or BMP-4 and by the observation that ES cells and EBs differentiated for 4 days in CDM alone respond to either factor within 24 h of addition. Another possibility is that there is a requirement for ES cell-or EB-derived auxiliary factors (e.g., nodal, FGF-5, BMP-2, or BMP-6), which take a few days to accumulate and act.
TGF-␤ family involvement in hematopoiesis. BMP-4 induces hematopoietic activity, including hematopoietic precursors, in developing EBs, as similarly observed in Xenopus animal cap explants (12, 30, 41) . Although this finding is suggestive of a direct involvement of BMP-4 in mesoderm transition to hematopoietic cells, this may not be the case. It is quite feasible that additional EB-derived factors, for example BMP-2, whose expression is mediated by BMP-4, are responsible. This is currently under investigation.
The transient expression of mesoderm markers observed in presence of a high concentration of BMP-4 suggests that the EBs progress rapidly to a non-brachyury-expressing mesoderm and various hematopoietic cells. Hematopoietic cells in the presomite embryo are derived from extraembryonic mesoderm, this is known not to express significant amounts of brachyury (73) . Together, these findings suggest that extraembryonic mesoderm forms under these conditions.
The lack of marked effects with other factors tested. Other members of both the TGF-␤ and the FGF families have been strongly implicated in mesoderm formation in nonmammals. However, in the system described here, TGF-␤1, -␤2, and -␤3, acid FGF, and basic FGF, when applied individually, did not produce any marked consistent increase of expression of the mesoderm markers tested. This apparent discrepancy may suggest that these factors normally operate in conjunction with others. It is also possible that they are involved in later cascades of induction, once competence has developed. However, it must be stated that the use of single factors in this manner is simplistic compared with what is known or suspected about normal embryonic development. Hence, the lack of striking effects with a single factor is not proof of (total) noninvolvement. Almost certainly these growth factors operate in concert with other factors.
Correlation of in vivo and in vitro results. In this report, it is shown that EBs respond to both activin A and BMP-4 in vitro; however, this is not formal proof of their involvement in mesoderm induction in vivo. For example, activin A or BMP-4 may bind to receptors of other untested or unknown factors that are responsible in vivo for mesoderm induction. To begin to answer this question, we examined the expression of both activin A and BMP-4 in vivo. Activin ␤A is present in the decidua, confirming the in situ data of Manova et al. (42) . Additionally, BMP-4 RNA is present in both the egg cylinder at 6.5 days p.c. and in undifferentiated ES cells, although the expression level is highly variable. The presence of both of these factors at this time is suggestive of maternal (decidua) and embryonic (primitive ectoderm, endoderm) tissues acting in concert. Such regionalization would be influenced by other components, such as extracellular matrix-binding BMP-4 (47) and the activin-binding protein follistatin, which is also present in the decidua at this time (31) . The complexity of these interactions is apparent in the different types of mesoderm which form, the changing kinetics observed in ES cell/EB differentiation, and the interdependent responses of growth factors to each other. This is consistent with the idea that mesoderm induction and subsequent development involve a number of dynamic, overlapping signals which progressively give rise to pattern formation (35, 75) .
Taken together, these data are compatible with a role for the TGF-␤ family in mesoderm formation in mammals. Here we have shown the effects of two exogenous factors; it would, however, be simplistic to believe that these two alone specify early mesoderm patterning. The importance of these factors in development awaits the results of further experiments, including specific gene disruptions. If such inductions are controlled by many overlapping highly plastic interactions, possibly involving competitive fields of influence, then single gene disruptions are unlikely to reveal a factor's full involvement in development.
